Galecto (GLTO) Earnings Date & Reports

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GLTO is expected to report earnings to fall 95.32% to -23 cents per share on August 30

Q2'24

Est.

$-0.24

Q4'24

Missed

by $4.84

Q1'24

Est.

$-0.20

Q4'23

Est.

$-0.35

Q3'23

Beat

by $0.04

The last earnings report on March 19 showed earnings per share of -513 cents, missing the estimate of -28 cents. With 19.90K shares outstanding, the current market capitalization sits at 3.77M.

View a ticker or compare two or three

Compare

GLTO